| Literature DB >> 28551725 |
Larissa V Furtado1, Wade S Samowitz2.
Abstract
Advances in defining the mutational landscape of colorectal cancer (CRC) over the past decades have revolutionized the molecular understanding and clinical testing algorithms for this disease. Mutation testing is standard of care for the work-up of CRCs. This review focuses on the current indications and strategies for molecular testing in CRC and discusses the potential changes in CRC testing approach associated with the emerging clinical application of genomic-based technologies.Entities:
Keywords: Biomarker; Colorectal cancer; IHC; Lynch syndrome; Next-generation sequencing; Personalized medicine
Mesh:
Substances:
Year: 2017 PMID: 28551725 DOI: 10.1007/s00428-017-2153-8
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064